Eastman Chemical (EMN) Misses Q4 EPS by 6c, Revs Beat

Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.81, $0.06 worse than the analyst estimate of $1.87. Revenue for the quarter came in at $2.69 billion versus the consensus estimate of $2.4 billion.

"Eastman made tremendous progress in 2021, delivering record sales revenue and adjusted EPS for the year. We are continuing to leverage our innovation-driven growth model to grow faster than our end markets. We also made outstanding progress advancing our leadership in the circular economy, including plans to build multiple world-scale material-to-material molecular recycling facilities," said Mark Costa, Board Chair and CEO. "I’m incredibly proud and appreciative of all that our employees did to work through very challenging conditions, stay focused on delivering record results, and advance our growth programs. We also remain focused on driving strong cash flow going forward and on continued disciplined allocation of cash. We are very excited about delivering continued success in 2022 and in the coming years."

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KeyBanc Upgrades Nucor (NUE) to Overweight
• BofA lists top 5 themes driving next $1tn in incremental semi sales